These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1795342)

  • 1. Severe polyarthropathy in an adolescent treated with pefloxacin.
    Le Loët X; Fessard C; Noblet C; Ait Saït L; Moore N
    J Rheumatol; 1991 Dec; 18(12):1941-2. PubMed ID: 1795342
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
    Kesseler A; Lacassie A; Hugot JP; Talon P; Thomas D; Astier L
    Ann Pediatr (Paris); 1989 Apr; 36(4):275-8. PubMed ID: 2742312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.
    Chevalier X; Albengres E; Voisin MC; Tillement JP; Larget-Piet B
    Drug Saf; 1992; 7(4):310-4. PubMed ID: 1524702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute gout in a patient taking pefloxacin--a case report.
    Kundu AK
    J Indian Med Assoc; 1996 Nov; 94(11):427. PubMed ID: 9141871
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arthropathy caused by pefloxacin. Report of a case. Histologic study of the synovia].
    Ollier S; Laroche M; Arlet P; Montane P; Durroux R; Le Tallec Y
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):671. PubMed ID: 2075409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Joint manifestations of pefloxacin in adolescents].
    Seigneuric C; Plantavid M; Bouygues D; Cassou M; Amar J; Cascarigny F
    Presse Med; 1990 Mar; 19(9):428. PubMed ID: 2138767
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
    Yap JC; Wang YT; Chan CC; Ng A; Poh SC
    Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polyarthropathy in an adolescent treated with pefloxacin].
    Chaslerie A; Bannwarth B; Fillol M; Joussein M; Laborde-Laulhe AM; Begaud B
    Therapie; 1992; 47(1):80. PubMed ID: 1523601
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case].
    Jorgensen C; Anaya JM; Didry C; Canovas F; Serre I; Baldet P; Ribard P; Kahn MF; Sany J
    Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):623-5. PubMed ID: 1775911
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with pefloxacin in patients with urinary tract infections.
    Chan PC; Cheng IK; Chan MK; Wong WT
    Br J Clin Pract; 1990 Dec; 44(12):564-7. PubMed ID: 2102145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pefloxacin in the treatment of severe infections in intensive care].
    Gritti G; Capuzzo M; Verri M; Nepoti ML; Nardini A
    Minerva Anestesiol; 1988 Sep; 54(9):367-72. PubMed ID: 3249624
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoroquinolones in children: poorly defined risk of joint damage.
    Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-effects of pefloxacin in idiopathic nephrotic syndrome.
    Aigrain EJ; Brun P; Bennasr S; Loirat C
    Lancet; 1993 Aug; 342(8868):438-9. PubMed ID: 8101937
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultra-short and short surgical prophylaxis with pefloxacin].
    Leo P; Mangione S
    Minerva Chir; 1994 Oct; 49(10):1031-7. PubMed ID: 7808660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pefloxacin in the treatment of recurrent urinary tract infections].
    Oksa A; Dzúriková V; Gajdos M; Krechnáková A; Krivosíková G; Ploczeková C; Spustová V
    Cas Lek Cesk; 1990 Jul; 129(30):953-6. PubMed ID: 2208227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of respiratory tract infections with pefloxacin].
    Królikowski W; Głuszko P; Soja J; Prokop A; Wandzilak M; Klisiewicz-Pańszczyk T; Jurek I; Gruszka M; Sek S; Musiał J
    Pol Arch Med Wewn; 1991 Apr; 85(4):210-4. PubMed ID: 1881829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pefloxacin in lower respiratory tract infections.
    Grassi C; Catena E; de Iola G; Ginesu F; Gori M; Lucchini M; Mangiarotti P; Micillo E; Onoscuri M; Orlandi O
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():103-10. PubMed ID: 2258337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ready-to-use pefloxacin infusion for surgical prophylaxis.
    Bapat RD; Mohite JD; Bowalekar SK; Raghu CN
    Adv Ther; 1994; 11(5):269-75. PubMed ID: 10150267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pefloxacin in the treatment of the bone and joint infections].
    Maiello A; Dassio G; Calvo MM; Gramoni A
    Minerva Med; 1999; 90(1-2):33-7. PubMed ID: 10388461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.